Mercado Global de Microfluídica – Tendências do Setor e Previsão para 2031

Análise e dimensão do mercado de microfluídica

Os dispositivos Lab-on-a-chip representam uma aplicação fundamental do mercado da microfluídica, aproveitando plataformas em miniatura que integram várias funções laboratoriais num único dispositivo microfluídico. A tecnologia Lab-on-a-chip permite testes rápidos e eficientes de amostras num formato compacto e portátil, oferecendo vantagens como volumes de amostras reduzidos, tempos de análise mais curtos e custos mais baixos em comparação com os métodos laboratoriais tradicionais. Encontram aplicações amplas no diagnóstico no local de prestação de cuidados, monitorização ambiental, descoberta de medicamentos e medicina personalizada, impulsionando a inovação e os avanços na saúde e nas ciências da vida.

O tamanho do mercado global de microfluídica foi avaliado em 26,65 mil milhões de dólares em 2023 e deverá atingir os 81,57 mil milhões de dólares até 2031, com um CAGR de 15,01% durante o período de previsão de 2024 a 2031. Para além dos insights sobre cenários de mercado, tais como valor de mercado , taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research também incluem análises especializadas aprofundadas, epidemiologia de pacientes, análise de pipeline, análise de preços e a estrutura regulatória.

Âmbito do relatório e segmentação de mercado       

Market Definition

Microfluidics is a multidisciplinary field that deals with the behavior, manipulation, and control of fluids at the microscale level, typically within channels with dimensions ranging from tens to hundreds of micrometers. It enables precise handling of small fluid volumes, making it valuable for various applications such as lab-on-a-chip devices, point-of-care diagnostics, and drug delivery systems.

Microfluidics Market Dynamics

Drivers

• Growing Advancements in Technology Expand the Scope of Applications for Microfluidics

Continuous innovation in areas such as material science, fabrication techniques, and detection methods drives the evolution of microfluidics technology, leading to the development of increasingly sophisticated microfluidic devices with enhanced capabilities. Advancements in software and automation streamline operation and data analysis, improving efficiency and reliability of microfluidics technology. These technological breakthroughs expand the scope of applications for microfluidics, spanning from healthcare to environmental sectors, and drive market growth by unlocking new opportunities for research, development, and commercialization of microfluidic-based solutions.

For instance, In August 2022, HORIBA's collaboration with SigTuple exemplifies the integration of microfluidics into advanced healthcare solutions. Combining microfluidics with AI, robotics, and cloud computing, SigTuple developed smart diagnostic solutions such as the AI100 for digital pathology. This collaboration underscores the pivotal role of microfluidics in enhancing the accuracy and efficiency of diagnostic processes, further aligning with the broader trend of leveraging technology to drive innovation and accessibility in healthcare.

• Growing Demand for Point-of-Care Diagnostics Increases the Demand for Microfluidic Devices

Point-of-care diagnostics offer rapid and convenient testing directly at the point of patient care, bypassing the need for centralized laboratory facilities and lengthy wait times for results. Microfluidic devices enable the development of compact and portable diagnostic tools that can perform a wide range of tests with high sensitivity and specificity using minimal sample volumes. With an increasing emphasis on early disease detection, remote monitoring, and personalized medicine, the demand for microfluidic-based point-of-care diagnostics continues to surge, driving market expansion.

Opportunities

• Escalating Chronic Diseases Increases the Demand for Microfluidic-Based Diagnostics

The rising prevalence of chronic diseases such as diabetes underscores the urgency for innovative diagnostic and therapeutic solutions. Microfluidic technologies offer a promising avenue, enabling the development of highly sensitive and portable diagnostic devices for early detection and monitoring. With diabetes cases projected to surge in Germany, reaching 6.5 million by 2030 according to IDF statistics, there is a pressing need for novel treatments. Microfluidic electrospray technology presents a viable solution, facilitating the creation of porous microcapsules encapsulating β cells for diabetes treatment. This convergence of rising disease burdens and technological advancements in microfluidics underscores its pivotal role in addressing healthcare challenges and driving market expansion.

• Increased Focus on Tailored Applications Leads to Development of New Microfluidic Products

The collaboration between Loschmidt laboratories and ETH Zurich partners in March 2021 exemplifies the drive for innovation in the microfluidics market. Creating a novel microfluidic platform, the team aims to investigate enzymes and their properties with enhanced efficiency and speed. This development aligns with the broader trend of developing new products in microfluidics to address specific applications, such as drug discovery and enzyme studies. The platform's versatility is showcased by its utilization in developing new thrombolytic for stroke treatment and studying the evolution of bioluminescent enzymes, highlighting its potential impact across diverse fields. Such collaborations underscore the dynamic nature of the microfluidics market, propelled by the pursuit of novel solutions to pressing healthcare and scientific challenges.

Restraints/Challenges

• Complexity of Integrating Microfluidic Technologies into Existing Workflows

Incorporating microfluidic devices into diverse industries such as healthcare, biotechnology, and manufacturing often requires extensive modifications and adaptations to existing processes. Technical challenges, compatibility issues, and the need for specialized infrastructure and expertise further complicate integration efforts. As a result, companies may hesitate to adopt microfluidic solutions, fearing disruptions to operations and potential inefficiencies.

• High Initial Investment Costs Impacting Microfluidic Technologies Implementation

The intricate design and fabrication processes involved in creating microfluidic devices require substantial financial resources for research, equipment, and infrastructure. This financial barrier can be particularly challenging for smaller companies and startups looking to enter the market, as they may struggle to secure the necessary funding. The initial investment costs can deter potential users from adopting microfluidic solutions, especially in industries with budget constraints or uncertain returns on investment. As a result, the high upfront costs associated with microfluidics can impede market growth and limit the widespread adoption of these innovative technologies.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• Em 2023, a Amar Equipment da Índia lançou o NanoMake, um dispositivo baseado em microfluídica que visa melhorar a investigação pré-clínica de vacinas de mRNA direcionadas para a COVID-19. Prevê-se que esta inovação avance significativamente no desenvolvimento de vacinas, simplificando os processos de investigação e aumentando a eficiência, contribuindo assim para o crescimento mais amplo do mercado de tecnologias baseadas em microfluídica.
• Em 2022, a Standard BioTools, Inc. lançou o sistema X9 Real-time PCR, aproveitando a tecnologia microfluídica para fornecer alta eficiência e saída de dados numa única execução. Este lançamento alargou o portefólio de produtos da empresa, atendendo à crescente procura de instrumentos genómicos avançados, e deverá reforçar a sua posição competitiva no mercado
• Em 2021, a Fluidigm lançou a plataforma de microfluídica Biomark X, destinada a otimizar os fluxos de trabalho laboratoriais, reduzindo o tempo prático e acelerando os resultados com uma saída de dados melhorada por execução. Esta inovação reflete o compromisso da Fluidigm em fornecer soluções de ponta para a investigação em ciências da vida, contribuindo assim para o crescimento do mercado e para o avanço das capacidades científicas.
• Em 2021, a aquisição da Applied Microarrays Inc. pela SCHOTT reforçou a sua presença nos EUA e melhorou as suas capacidades em biociências. Este movimento estratégico permitiu à SCHOTT ampliar o seu portefólio de soluções de microarranjos, aproveitando a experiência da Applied Microarrays para reforçar a sua posição no mercado de biociências em rápida evolução

Âmbito do mercado de microfluídica

O mercado está segmentado com base no tipo de produto, material, tecnologia, aplicação, setor e utilizador final. O crescimento entre estes segmentos irá ajudá-lo a analisar os escassos segmentos de crescimento nas indústrias e fornecer aos utilizadores uma valiosa visão geral do mercado e insights de mercado para os ajudar a tomar decisões estratégicas para identificar as principais aplicações do mercado.

Tipo de produto

• Dispositivos baseados em microfluidos
• Componentes Microfluídicos

Material

• Polímero
• Copo
• Silício
• Metal
• Cerâmica
• PDMS
• Outro

Tecnologia

• Medicina/Saúde
• Não médico

Aplicação

• Diagnóstico in vitro
• Teste no local de atendimento
• Diagnóstico Clínico
• Investigação Farmacêutica
• Análise de laboratório
• Microdistribuição
• Microrreação
• Entrega de medicamentos
• Testes de Laboratório
• Teste Analítico
• Triagem de alto rendimento

Setor

• Industrial
• Assistência médica
• Diagnóstico in vitro
• Pesquisa Ambiental
• Diagnóstico Clínico

Utilizador final

• Hospitais e Centros de Diagnóstico
• Institutos Académicos e de Investigação
• Empresas Farmacêuticas e de Biotecnologia

Análise/perspetivas regionais do mercado de microfluídica

O mercado é analisado e os insights e tendências do tamanho do mercado são fornecidos por tipo de produto, material, tecnologia, aplicação, setor e utilizador final, como mencionado acima.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates in the market is propelled by its vibrant research landscape, where esteemed institutions drive innovation in novel microfluidic devices. With a rich ecosystem of academic and industrial collaboration, the region fosters cutting-edge research and development initiatives. This synergy between academia and industry cultivates a fertile ground for pioneering advancements, positioning North America as a global leader in microfluidic technologies. As a result, the region consistently produces groundbreaking solutions, attracting significant investments and solidifying its preeminence in this rapidly evolving field.

The Asia-Pacific is expected for rapid growth in the market, primarily due to heightened government backing for infrastructure development and the strengthening of intellectual property rights. This support fosters an environment conducive to innovation and investment, attracting both domestic and foreign capital. As infrastructure improves, it facilitates smoother trade and connectivity, bolstering economic activity across various sectors. Robust intellectual property protections incentivize research and development, fostering a culture of innovation and driving long-term economic expansion in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Microfluidics Market Analysis

O cenário competitivo do mercado fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas em relação ao mercado.

Alguns dos principais players que operam no mercado são:

• Danaher (EUA)
• Thermo Fisher Scientific Inc.
• (EUA)
• (EUA)
• (EUA)
• BD (EUA)
• (EUA)
• F. Hoffmann-La Roche (Suíça)
• Fluidigm Corporation (EUA)
• Microfluídica Dolomita (Reino Unido)
• QIAGEN (Alemanha)
• Abbott (EUA)
• BIOMÉRIEUX (França)
• microfluídico ChipShop GmbH (Alemanha)
• Elveflow (França)
• Celix Bio. (Índia)
• Micronit BV (Holanda)
• PARKER HANNIFIN CORP (EUA)
• Fortivo (EUA)

SKU-10534